BCP Meeting - March 16, 2017

Announcement Description

Biotechnology/Chemical/Pharmaceutical Customer Partnership


Thursday, March 16, 2017

United States Patent and Trademark Office

USPTO Main Campus (Alexandria), Madison Auditorium



10:00 – 10:10am (EDT)

Welcoming and Opening Remarks

Jerry Lorengo

Director, TC1600, USPTO


Daniel Sullivan

Director, TC1600, USPTO


Wanda Walker

Director, TC1600, USPTO



10:10 – 11:10am (EDT)

Rationale Statements in 35 U.S.C. 103

Cassandra Spyrou, Supervisory Review Quality Assurance Specialist, OPQA, USPTO




11:10am – 12:00pm (EDT)

The Role of Inherency in Making an Obviousness Determination

William Smith, Of Counsel, BakerHostetler







12:00 – 1:00pm (EDT)










1:002:00pm (EDT)

Range Analysis

Jean Witz, SPE, CRU, USPTO




2:00 – 2:40pm (EDT)


37 CFR §1.132 Practice, Unexpected Results

Scarlett Goon, QAS, TC1600, USPTO




2:40 – 2:50pm (EDT)







2:50 – 3:50pm (EDT)

Interviews (From the Startup Perspective)

Charles Andres, Associate, Patent and Innovation, WSGR





3:50 – 4:30pm (EDT)

Interview Training (USPTO)


Frederick Krass, SPE, TC1600, USPTO





4:30 – 4:40pm (EDT)


Closing Remarks

Directors, TC1600, USPTO









Created at 3/23/2017 10:01 PM by John Marquardt
Last modified at 3/23/2017 10:01 PM by John Marquardt